J Korean Soc Ther Radiol.  1990 Jun;8(1):29-34.

Radiation Therapy of Nasopharyngeal Carcinoma KCCH Experience (1964~1984)

Affiliations
  • 1Department of Therapeutic Radiology, Korea Cancer Center Hospital, Seoul, Korea.
  • 2Department of Otolaryngology-Head and neck Surgery, Korea Cancer Center Hospital, Seoul, Korea.

Abstract

Total of 154 patients of pathologically proven and previously untreated nasopharyngeal carcinoma who were treated in the Department of Therapeutic Radiology, Korea Cancer Center Hospital during the period from 1964 to 1984 were analyzed. Minimal follow-up period of survivors was 3 years. Thirteen percent of the patients had T4 primary lesions and 65% had stage IV disease. Total radiation dose to the primary site was 1550~1750 ret in 82 and above 1750 ret in 72 patients. Local control was obtained in 79% of patients. Significant prognostic factors for the survival were tumor dose (above vs. below 1750 ret), age (below vs. above 30 years), stage (AJCC I-III vs IV), T stage (T1 vs. T2-4), and N stage (NO vs. N+).

Keyword

Nasopharyngeal carcinoma

MeSH Terms

Follow-Up Studies
Humans
Korea
Radiation Oncology
Survivors
Full Text Links
  • JKSTR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr